Moving forward, robust longitudinal clinical studies, mechanistic elucidation, and personalized microbiome profiling will be critical to transforming this emerging science into actionable therapies for neurodegenerative disease
For instance, MPTPs selective destruction of dopaminergic neurons via mitochondrial complex I inhibition is a well-documented cause of drug-induced parkinsonism
A healthcare provider can help tailor treatment plans to individual needs, ensuring that any intervention, including carnitine supplementation, is both safe and effective
Molecular mechanism-driven discovery of novel small molecule inhibitors against drug-resistant SARS-CoV-2 M(pro) variants
however, in vivo, one could imagine that repeated 5FU exposures would drive selection of pre-existing niches of tumours cells that had higher mitochondrial functionality
tumor growth, metabolic effects) against benefits before initiating therapy in each patient